We've moved! Same resources, new address:

Find resources

Total results with these characteristics: 155

Disease: Influenza

Page 4 of 8
Influenza Vaccination of Pregnant Women and Protection of Their Infants

This article, published in the New England Journal of Medicine, presents results from two double-blind, randomized, placebo-controlled trials of trivalent inactivated influenza vaccine (IIV3) in South Africa during 2011 in pregnant women infected …

Author: Madhi SA, Cutland CL, Kuwanda L, et al.

Publication date: 2014

Influenza Vaccine Effectiveness in the United States During the 2015–2016 Season

This article, published in The New England Journal of Medicine, reports the results of a study to examine the effectiveness of the live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) formulations used in the 2015–2016 …

Author: Jackson ML, Chung JR, Jackson LA, et al.

Publication date: 2017

Influenza Vaccine for Pregnant Women in Resource-Constrained Countries: A Review of the Evidence to Inform Policy Decisions

While influenza vaccination of pregnant women may be justified on the basis of preventing maternal disease alone, demonstrating additional benefits to the newborn is important to inform policy decisions in areas with limited resources and many …

Author: Ortiz JR, Englund JA, Neuzil KM

Publication date: 2011

Influenza Vaccine Manufacture: Keeping Up With Change

This editorial, published in the Journal of Infectious Diseases, discusses challenges in influenza vaccine development, including the characteristics of the virus and vaccine production.

Author: Neuzil KM, Bright RA

Publication date: 2009

Influenza Vaccine Strategies for Broad Global Access

This paper analyzes the current supply of influenza vaccines, the predicted demand for influenza vaccines in case of a pandemic, and new vaccine technologies that could provide for the world’s demand in a pandemic situation.

Author: PATH

Publication date: 2007

Influenza Vaccine Supply: Building Long-Term Sustainability

This article, published in the journal Vaccine, discusses the importance of building long-term sustainability for influenza vaccine supply. This is important for seasonal vaccination, as well as pandemic vaccine supply, which will rely on the same …

Author: Hehme N, Colegate T, Palache B, Hessel L

Publication date: 2008

Influenza Vaccines for the Future

This review article, published in the New England Journal of Medicine, provides an overview of currently available influenza vaccines and new technologies in influenza vaccine production. The authors further offer a perspective on the …

Author: Lambert LC, Fauci AS

Publication date: 2010

Influenza Vaccines: More Options and More Opportunities

This article, published in The Journal of Infectious Diseases, discusses the value of comparative studies of influenza vaccines, which provide a uniform way to evaluate the relative performance of different vaccines. The author argues that such …

Author: Neuzil KM

Publication date: 2012

Influenza Virus Traceability Mechanism

In November 2007, the Intergovernmental Meeting on Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines and Other Benefits, requested that the World Health Organization (WHO) develop an Influenza Virus Traceability …

Author: World Health Organization

Information on Avian Influenza

This web page provides important information for the public, health professionals, and travelers on avian influenza, including key facts on how the virus is spread and treatment for avian influenza.

Author: US Centers for Disease Control and Prevention

Intradermal Delivery of Vaccines: A Review of the Literature and the Potential for Development for Use in Low- and Middle-Income Countries

The purpose of this report is: (1) to summarize the clinical evidence supporting the intradermal route for vaccine administration and the devices being developed for this purpose; (2) to determine whether intradermal delivery broadly holds promise …

Author: PATH

Publication date: 2009

Investigating Live Attenuated Influenza Vaccine Efficacy in Senegal

This fact sheet describes a Phase 3 clinical study that PATH and its partners are conducting in Senegal to evaluate the clinical efficacy of a seasonal, trivalent live attenuated influenza vaccine (LAIV). By providing evidence on how well this type …

Author: PATH

Publication date: 2013

Joint Vaccine Education Resource Center

This website provides resources in the field of immunization, including an extensive selection of peer-reviewed articles from the literature as well as links to valuable resources for scientists, clinicians, and patients focused on the most commonly …

Author: American Journal of Preventative Medicine; Vaccine

Jordan Report: Accelerated Development of Vaccines 2012

This comprehensive report includes expert articles on a variety of vaccine-related topics and updates on vaccine research for specific infectious diseases, such as influenza, malaria, respiratory syncytial virus, and rotavirus.

Author: US National Institute of Allergy and Infectious Diseases

Publication date: 2012

Landscape Analysis: Trends in Vaccine Availability and Novel Vaccine Delivery Technologies: 2008–2025

This landscape analysis identifies trends in the availability of vaccines and novel vaccine delivery technologies that are and will be of relevance to low- and middle-income countries from the present through 2025.

Author: PATH, World Health Organization

Publication date: 2008

Live Attenuated H7N7 Influenza Vaccine Primes for a Vigorous Antibody Response to Inactivated H7N7 Influenza Vaccine

This article, published in Vaccine, reports on a study to evaluate the safety and immunogenicity of two candidate H7 pandemic live attenuated influenza vaccines (pLAIVs) and their ability to prime for responses to an unadjuvanted H7 pandemic …

Author: Babu TM, Levine M, Fitzgerald T, et al.

Publication date: 2014

A Live Attenuated Influenza A(H5N1) Vaccine Induces Long-Term Immunity in the Absence of a Primary Antibody Response

This article, published in The Journal of Infectious Diseases, reports on a study on whether two influenza A(H5N1) live attenuated vaccines for pandemic use (pLAIVs) primed or established long-lasting immunity that could be detected by …

Author: Talaat KR, Luke CJ, Khurana S, et al.

Publication date: 2014

Maternal Immunization Against Viral Disease

This article, published in Vaccine, discusses the advantages and disadvantages of maternal immunization to augment the protective effect of maternal antibody against many viral diseases in the young infant. The authors also present more specific …

Author: Englund J, Glezen WP, Piedra PA

Publication date: 1998

Maternal Immunization: Country Priorities and Market Requirements

Maternal immunization is an approach of vaccinating during pregnancy to enhance immunity for both mother and baby. This report provides insight into country priorities for maternal immunization and characterizes the market for adult immunizations in …

Author: PATH

Publication date: 2015

Maternal Immunization Safety Monitoring in Low- and Middle-Income Countries: A Roadmap for Program Development

Maternal immunization holds the promise of further reducing morbidity and mortality among pregnant women and infants, particularly in low- and middle-income countries (LMICs) where there is the greatest burden of vaccine-preventable disease. This …

Author: Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)

Publication date: 2017

Page 4 of 8